FDA NDC Directory · JSON-LD · Markdown

Lisdexamfetamine Dimesylate

NDC 0054-0371 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namelisdexamfetamine dimesylate
Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202827
Dosage form / routeCAPSULE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (30 mg/1)
Marketing started20230825
Package count1

External sources

Source: openFDA. Public-domain (CC0).